Radio and PodcastRadio and PodcastLive Radio & Podcasts
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma artwork
Science & Medicine

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association

Oct 24, 202420:41Science & Medicine

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–P...

About This Episode

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma is an episode from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medi...

Podcast

This episode belongs to JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Oct 24, 2024, 20:41 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.

Questions About This Episode

What is Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma about?

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

Where can I listen to Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma?

You can listen to Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma from?

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma is an episode from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association.

How long is this episode?

This episode is 20:41 long.

When was this episode published?

This episode was published on Oct 24, 2024.

Can I save Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer?

Yes. This page shows related episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma?

You can listen to Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma is from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association.

What are the episode details?

Published Oct 24, 2024 and 20:41 long